Referral Rate for, and Uptake of Genetic Testing in Women Diagnosed with Breast Cancer ≤ 35 and Triple Negative Breast Cancer (TNBC) ≤ 50
| Autor: | B Alsulami, Elit Laurie, M Sameer, Bordeleau Louise, Pond Greg, Murphy Amber, M Al Saqer, Bell Kathleen, A Alathem, N Ahmadi |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Oncology
medicine.medical_specialty business.industry General Engineering Estrogen receptor Cancer Disease medicine.disease Malignancy Breast cancer Internal medicine medicine General Earth and Planetary Sciences Biomarker (medicine) Receptor business Triple-negative breast cancer General Environmental Science |
| Zdroj: | Annals of Breast Cancer and Therapy. 1 |
| ISSN: | 2578-6512 |
| DOI: | 10.36959/739/515 |
| Popis: | Breast cancer is a potentially fatal malignancy. This form of cancer is the most common among Western women. Breast cancer is a heterogeneous disease. Clinically, one can classify it based on biomarker expression (e.g. estrogen receptors, progesterone receptors, and HER-2 expression). Triple negative breast cancer is a unique type where the tumors are negative for estrogen receptors, progesterone receptors, and HER-2 expression which results in a more aggressive biology and treatment approach. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|